Peter Thompson, MD
Plastic Surgery · Atlanta, GANPI 1194902288
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,395 of the $5,875 with a category attached, or 74.8%. 12 manufacturers reported payments, led by Axogen at 25.6% of the total.
Across 110 payments — averaging $53.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$2K
- AbbVie$1K
- Mentor Worldwide LLC$1K
- Davol Inc.$884
- Integra Lifesciences Corporation$490
- Merck$125
- plus $265 from 6 others
What the payments were for
- Speaking & faculty fees$4508%
- Travel & lodging$70412%
- Food & beverage$4,39575%
- Other$3266%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 9 | $1,501 |
| AbbVie | 53 | $1,445 |
| Mentor Worldwide LLC | 24 | $1,165 |
| Davol Inc. | 6 | $884 |
| Integra Lifesciences Corporation | 8 | $490 |
| Merck | 1 | $125 |
| Kerecis Limited | 1 | $75 |
| Johnson & Johnson(2 entities) | 2 | $65 |
| Smith+Nephew | 1 | $47 |
| RTI Surgical, Inc | 3 | $39 |
| Biocircuit Technologies Inc | 1 | $23 |
| Motiva USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,875 in reported general payments places this provider in the 70th percentile of 163 plastic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 21 | $116 |
| Gabapentin | 38 | $113 |
| Tramadol Hcl | 24 | $48 |
| Ibuprofen | 24 | $46 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Atlanta
- Albert LoskenAtlanta$436K
- Jonathan NguyenAtlanta$364K
- Brian MaloneyAtlanta$224K
- Farzad NahaiAtlanta$129K
- Sara NeimanisAtlanta$51K
- Alan LarsenAtlanta$48K
- Foad NahaiAtlanta$29K
- Bahair GhaziAtlanta$17K
- Drew MetcalfeAtlanta$14K
- John SymbasAtlanta$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.